The Global Cannabinoid Therapeutics Market was valued at USD 27.37 billion and is projected to reach a market size of USD 111.37 billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 22.2%.
Industry Overview:
Cannabis, which is used to treat various conditions and illnesses, comes from either a marijuana plant or a chemical. It is similar to marijuana used for recreational purposes, but it is also used for medicinal purposes.
Cannabis drug market :
Marijuana plants contain about 100 chemicals, also known as cannabinoids. The effects of marijuana and cannabis vary from person to person. The chemicals used primarily in the medical field are cannabidiol (CBD) and Delta9-tetrahydrocannabinol (THC). THC also creates a sensation when a person smokes or consumes marijuana.
Medical marijuana is used to treat a variety of illnesses, including:
There is different evidence linking cannabis to different effects in the therapeutic field. B. Ability to reduce chronic pain, vomiting, and nausea caused by spasticity and chemotherapy. Cannabinoids affect memory, appetite, pain, and exercise.
Due to its therapeutic effect, cannabis is being legalized and non-criminalized in various countries. For example, medicated cannabis is legal in countries such as the United States, Canada, the United Kingdom, Croatia, the Czech Republic, Cyprus, Colombia, Chile, Australia, Barbados, Denmark, Finland, Poland, and Portugal. In addition, ongoing political movements in support of the legalization of cannabis are driving the cannabis drug market.
For example, in May 2021, US representatives reintroduced the MORE (Marijuana Opportunity, Reinvestment, and Elimination) Act in the US House of Representatives. In addition, in December 2020, the MORE Act previously passed the House of Representatives but was unable to move forward in the Senate. If the MORE Act is passed, the demand for cannabis products in the United States will increase. This, in turn, is estimated to have a positive impact on the growth of the pharmaceutical cannabis market.
It is estimated that increasing consumer acceptance will increase the number of cannabis doctors prescribing cannabis products, increasing market potential. For example, the number of healthcare workers registered with Canadian licensed vendors increased from 6,700 in September 2019 to 7,781 in March 2021. In addition, increasing consumer recruitment is supporting the growth of the cannabis medical market. According to the Centers for Disease Control and Prevention, 48.2 million people in the United States, or 18% of the US population, used marijuana at least once in 2019.
COVID-19 impact on Cannabinoid Therapeutics Market
The COVID 19 pandemic and its associated norms of social distance and blockade have affected all industries around the world. While the COVID 19 pandemic negatively impacted sales in various product categories, the leading cannabis drug brand Epidiolex achieved positive sales growth. This is due to high customer satisfaction and high replenishment rates due to increased payer coverage. Legal cannabis sales increased dramatically during the 2020 COVID-19 pandemic.
For example, according to Leafly, a leading cannabis website, Americans bought $ 10.7 billion worth of cannabis and its products in 2019 which increased to $ 18.3 billion in 2020. The Governor of various states in the United States has declared cannabis a necessity. In addition, many retailers and pharmacies have begun offering cannabis products through online sales channels. Therefore, it is estimated that increased consumption of cannabis products will have a positive impact on market growth.
Pharmaceutical and biotechnology companies are working with governments around the world to control the outbreak of COVID 19, from supporting vaccine development to planning drug supply chain challenges. Currently, there are about 115 vaccine candidates and 155 molecules in the R & D pipeline.
In addition, commonly used medicines such as hydroxychloroquine have dramatically increased the demand for the treatment of COVID19. Such high demand for these drugs has provided tremendous opportunities for COVID-19 pharmaceutical companies, as many developed countries are short of these drugs. Demand for COVID19 vaccines and therapeutics is expected to lead to significant growth in the pharmaceutical and biotechnology industries in the future. Due to these factors, COVID 19 is expected to have a significant impact on the cannabis medical market.
MARKET DRIVERS:
Increases in the legalization of Medicinal Cannabis in Economics and Growing usage of Cannabis In Pharmaceutical Items Is Driving the Growth of the Market:
There has been an increase in the legalization Of Medicinal Cannabis in Economics which is driving this market. Countries like America, Germany Etc are making great progress n this section of medicines. These big economies will make this market even bigger. The medicine market for this is very large in these countries which makes it an even more driven market. There has been a growing usage of Cannabis-based Pharmaceuticals for Various indications such as inflammation Chronic pain, and Sleep disorders. Other than that there are many cases related to the pharmaceutical firms which make drugs and medicines using this cannabis which makes its market more driven in the world.
Growing Awareness about the Benefits of Cannabis:
Cannabis has been used In many medical purposes which is why it has been the best in the market. Cannabis has shown some extraordinary benefits which are driving its need. Many patients who are suffering from diseases like Depression, Anxiety, and other medical conditions have shown changes and better health after using this as a medicine. Nowadays about 60% of the people , once in their life suffers from Anxiety and Depression but they don’t have any treatment for that. these cannabis might work good on them since these cannabis relaxes the mind and help one In fighting with the thoughts.
MARKET RESTRAINTS:
High Price Associated with Medical Cannabis and Adverse Effects On Health Sometimes is Rstraining the Growth of the Market:
Some people found that cannabis is basically very High priced which is why this has been one of the important aspects which has to be kept In mind while doing anything. While purchasing any medicine everyone checks the price and also compares it with the other brand with the same purpose solving which makes it an even bigger concern. Usually, the medicines which are made using these are highly-priced which makes it difficult to afford for some people.
There are many cases that have been seen when patients taking cannabis or medicines made from this cannabis often have many side effects which makes it even more difficult to use. Many people are already afraid to use these products but once they use them some of them become addicted to it which makes a restraint in the market.
CANNABINOID THERAPEUTICS MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2022 - 2030 |
|
Base Year |
2022 |
|
Forecast Period |
2023 - 2030 |
|
CAGR |
22.2% |
|
Segments Covered |
By Brand, Application, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
GW Pharmaceuticals, Insys therapeutics Abbvie, Valeant Pharmaceuticals |
This research report on the Cannabinoid Therapeutics Market has been segmented and sub-segmented based on type, application, delivery mode, end-user, and region.
Sativex
Epidiolex
The Epidiolex phase ruled the marketplace for hashish prescription drugs accounted for the most important sales proportion in 2021 and is envisioned to be the fastest-developing phase at some point of the forecast period. This is attributed to the excessive income of Epidiolex. According to GW prescription drugs annual report, Epidiolex income elevated by extra than 70% in 2020 from 2019 no matter COVID-19. This is because of the sturdy call for Epidiolex from the U.S. and Europe. Moreover, pricing and compensation approval in Finland, Germany, and Israel is assisting marketplace growth. Epidiolex is used withinside the remedy of seizures related to Dravet syndrome and Lennox-Gastaut syndrome. The growing variety of approvals of Epidiolex is riding the phase growth.
The Sativex phase is envisioned to witness a CAGR of 26.9% at some point in the forecast period. Sativex is used to deal with muscle spasticity because of more than one sclerosis. Increasing call for Sativex to be used in muscle spasticity in Canada, and European international locations are riding the phase growth. Moreover, a growth withinside the variety of medical trials of the drug for different scientific situations consisting of posttraumatic pressure disorder, spinal twine injury, different neurological situations, cancer, and persistent ache is similarly anticipated to power the marketplace for hashish prescription drugs over the forecast period. For instance, a medical take a look at subsidized through GW Pharmaceuticals, Inc. in collaboration with Otsuka Pharmaceutical Development and Commercialization, Inc. changed into finished in 2018. This takes a look at changes geared toward studying the consequences of Sativex for alleviating ache in sufferers with superior cancer. In addition, a randomized managed trial posted withinside the National Library of Medicine in 2019 analyzed using Sativex spray as a further remedy for more than one sclerosis spasticity.
Medical
Recreational
Edibles
Topicals
Industrial hemp
Others
Based on application, Some of the current uses of cannabinoids include: Alleviating pain and inflammation, especially chronic forms, from diseases such as arthritis, fibromyalgia, endometriosis, glaucoma, neuropathy, and Crohn's disease. Increasing appetite to prevent the extreme weight loss of AIDS. There is an increase in the application of cannabinoids which is very useful in many cases. Due to various applications in various markets, there is growth which is seen in the market. The market has been seeing a healthy CAGR in the application. Cancer is the biggest achievement which has been cured in many cases using these medicines which is great news.
North America
Europe
Asia-Pacific
Latin America
Rest Of the World
Geographically Europe dominated the market of cannabis drugs and controls the maximum occupancy of sales of 43.8% by 2021. This is due to an increase in cannabis consumption, as well as an increase in caution and prospective attitude towards cannabis and its products. The existence of major cannabis main manufacturers in this area and various initiatives support market growth. For example, August, August 2020, 2020, IP is a Portugal regulatory authority, that appreciated licenses for clever leaves, a cloverleaf for cultivation, export, and a cloverleaf for export. . Medical marijuana legalization in Germany in January 2017. Therefore, the increasing legalization of cannabis and its products for medical purposes is presumed to drive market growth potential.
However, in the Middle East and Africa, the medical cannabis market is expected to register the fastest growth rate of 110.2% during the forecast period. Increased legalization of cannabis, increased awareness of its health benefits, and approval of medicinal use of cannabis are factors that are expected to drive growth in the Middle East and Africa region over the projected period. In addition, cannabis cultivation is growing rapidly in Africa. Several countries, including Lesotho, South Africa, Malawi, Zambia, Rwanda, and Ghana, have legalized the cultivation of medical cannabis. It, in turn, needs to drive the local market.
Cannabinoid Therapeutics Market Share by company
Companies like:
Pharmaceutical companies, research institutes, and beauty care are the major consumers in the cannabis medical market. Various researchers have been researching cannabis chemicals to discover new drugs. Pharmaceutical companies have been hit by the influx of medical marijuana prescriptions. Various pharmaceutical companies are incorporating cannabis into their portfolios and strategies.
Cannabis is also used in the fields of beauty and wellness and is growing rapidly. In particular, CBD oil is getting a lot of attention among people. Key players in the cannabis drug market are adopting a variety of strategies, including mergers, acquisitions, and product development, to expand their product portfolio and geographic footprint. For example,
in February 2021, Jazz Pharmaceuticals PLC announced plans to acquire GW Pharmaceuticals. Upon completion of the acquisition, Jazz Pharmaceutical will expand its neuroscience product portfolio, expanding its global commercial footprint. Some of the prominent players in the cannabis drug market are. These companies are making a great number of increases in this market which is very great news.
NOTABLE HAPPENINGS IN THE CANNABINOID THERAPEUTICS MARKET IN THE RECENT PAST:
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
